GO:0051254 positive regulation of RNA metabolic process: RNA Processing Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051254 describes any process that activates or increases the frequency, rate or extent of RNA metabolism, including transcription, processing, and turnover.
• The term is a broad biological_process ontology node that captures positive regulation across all RNA species and RNA-related reactions.
• Microarray studies in porcine oocytes identified this ontology group as highly regulated during in vitro maturation, linking it to developmental competence.
• RNA metabolic positive regulation is mediated by RNA-binding proteins, splicing factors, and noncoding RNAs that stabilize or process RNA transcripts [1,5,6].
• Dysregulation of RNA metabolic positive regulation contributes to cancer, cardiovascular disease, and metabolic disorders [1,4,5,6].
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of genes controlling RNA metabolic positive regulation [5,6].
Description
GO:0051254, positive regulation of RNA metabolic process, is a Gene Ontology biological_process term defined as any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving RNA. This term sits at a high level of the ontology hierarchy, encompassing positive regulation of transcription, RNA processing, splicing, modification, and degradation. It is a critical node for understanding how cells boost RNA output or stability in response to developmental, metabolic, or stress signals [2,4]. Researchers use this term to annotate gene sets that coordinately upregulate RNA metabolism, as demonstrated in porcine oocyte maturation where the ontology group was highly regulated. The term is also relevant to disease contexts, including myocardial ischemia-reperfusion injury, where circMIRIAF aggravates injury via the miR-544/WDR12 axis and impacts RNA metabolic regulation. In cancer, LINC00982-encoded PRDM16-DT regulates CHEK2 splicing to suppress metastasis and chemoresistance, illustrating how positive regulation of RNA metabolism can be co-opted in malignancy. Similarly, human antigen R stabilizes autophagy-associated mRNA in calcific aortic valve disease, directly linking RNA metabolic positive regulation to cardiovascular pathology. Understanding GO:0051254 therefore provides a framework for interrogating how cells amplify RNA-related processes and how this amplification goes awry in disease.
positive regulation of RNA metabolic process At A Glance
| GO ID | GO:0051254 |
|---|---|
| GO term | positive regulation of RNA metabolic process |
| Ontology | biological_process |
| Synonym | activation of RNA metabolic process; positive regulation of RNA metabolism; stimulation of RNA metabolic process; up regulation of RNA metabolic process; up-regulation of RNA metabolic process; upregulation of RNA metabolic process |
| Major function | Activates or increases the frequency, rate or extent of chemical reactions and pathways involving RNA. |
| Related processes | Positive regulation of transcription, RNA splicing, RNA stability, RNA modification, and RNA catabolism. |
| Example annotation | Highly regulated ontology group in porcine oocytes matured in vitro. |
| Disease relevance | Implicated in myocardial ischemia-reperfusion injury, cancer metastasis, and calcific aortic valve disease [1,5,6]. |
What Is GO:0051254?
In our own words, GO:0051254 refers to any biological process that increases the rate, frequency, or extent of RNA metabolism. This includes positive regulation of transcription, RNA splicing, RNA modification, RNA transport, and RNA decay. It is a regulatory term that describes upstream or downstream events that enhance the chemical reactions and pathways involving RNA, rather than the RNA metabolic reactions themselves.
Why Is positive regulation of RNA metabolic process Important in Cell Biology?
GO:0051254 is important because it provides a unified ontology framework for studying how cells amplify RNA metabolism, a process essential for development, differentiation, and stress responses. Dysregulation of this process is linked to a wide range of human diseases, including cardiovascular injury, cancer progression, and metabolic disorders [1,4,5,6]. By annotating genes and gene sets with this term, researchers can systematically identify pathways that boost RNA output and stability, enabling mechanistic studies and therapeutic target discovery [2,5].
• Enables systematic annotation of genes that upregulate RNA metabolism in development and disease.
• Links RNA processing and stability to myocardial ischemia-reperfusion injury through circMIRIAF/miR-544/WDR12 axis.
• Connects splicing regulation by PRDM16-DT to colorectal cancer metastasis and chemoresistance.
• Highlights the role of RNA-binding proteins like human antigen R in stabilizing autophagy-associated mRNA in cardiovascular disease.
• Provides a framework for studying metabolic regulation by SIRT7 in brown adipose tissue and thermogenesis.
• Supports investigation of RNA-mediated regulation in bacterial pathogens, including Gram-positive bacteria [7,8].
• Facilitates CRISPR-based functional genomics of RNA metabolic positive regulators [5,6].
• Aids in interpreting transcriptomic and proteomic data by grouping co-regulated RNA metabolism genes.
• Guides development of RNA-targeted therapeutics for cancer and cardiovascular disease [1,5,6].
• Enhances cross-species comparisons of RNA metabolic regulation, from oocytes to pathogens [2,7,8].
What Happens During positive regulation of RNA metabolic process?
Initiation of RNA metabolic activation
In simple terms: Cells receive signals that tell them to make or process more RNA.
Positive regulation of RNA metabolic process begins when extracellular or intracellular signals activate transcription factors, RNA-binding proteins, or noncoding RNAs that enhance RNA metabolism [2,4]. For example, in porcine oocytes matured in vitro, the ontology group positive regulation of RNA metabolic process is highly regulated, indicating active upregulation of RNA-related pathways during maturation. Similarly, SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions, which involves modulation of RNA metabolic processes.
Amplification of RNA processing and splicing
In simple terms: The cell increases the editing and maturation of RNA molecules.
Once activated, positive regulation of RNA metabolic process can enhance splicing, capping, polyadenylation, and editing of RNA transcripts. LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance, demonstrating how a noncoding RNA-encoded protein can positively regulate RNA splicing. A hairpin ribozyme derived spliceozyme further illustrates engineered RNA processing mechanisms that can be co-opted for research.
Stabilization and turnover of RNA
In simple terms: RNA molecules are protected from degradation or targeted for breakdown.
Positive regulation of RNA metabolic process also includes stabilization of RNA transcripts by RNA-binding proteins. Human antigen R regulates autophagic flux by stabilizing autophagy-associated mRNA in calcific aortic valve disease, directly linking mRNA stabilization to disease pathology. In myocardial ischemia-reperfusion injury, circMIRIAF aggravates injury via targeting miR-544/WDR12 axis, affecting RNA metabolic regulation.
Integration with cellular metabolism
In simple terms: RNA metabolism is coordinated with energy and metabolic state.
RNA metabolic positive regulation is integrated with cellular metabolism. SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice, indicating crosstalk between RNA metabolism and metabolic control. In bacteria, RNA-mediated regulation in Gram-positive pathogens, including group A Streptococcus, highlights how RNA metabolic processes are positively regulated for adaptation. The complex Rcs regulatory cascade in bacteria also exemplifies positive regulation of RNA metabolism in response to environmental signals.
Key Genes Involved in GO:0051254 positive regulation of RNA metabolic process
The following genes and proteins are experimentally implicated in positive regulation of RNA metabolic process, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| circMIRIAF | Noncoding RNA that targets miR-544/WDR12 axis | Aggravates myocardial ischemia-reperfusion injury |
| WDR12 | Target of miR-544, involved in RNA metabolism | Implicated in myocardial ischemia-reperfusion injury |
| SIRT7 | NAD-dependent deacetylase regulating thermogenesis | Suppresses energy expenditure via brown adipose tissue |
| PRDM16-DT | LINC00982-encoded protein regulating CHEK2 splicing | Suppresses colorectal cancer metastasis and chemoresistance |
| CHEK2 | Checkpoint kinase 2, splicing target | Regulated by PRDM16-DT in colorectal cancer |
| Human antigen R (HuR) | RNA-binding protein stabilizing mRNAs | Regulates autophagic flux in calcific aortic valve disease |
| Rcs cascade components | Bacterial regulatory cascade | Complex Rcs regulatory cascade in bacteria |
| Group A Streptococcus RNA regulators | RNA-mediated regulation in Gram-positive pathogens | Overview of RNA regulation in pathogens |
| Spliceozyme | Engineered hairpin ribozyme-derived RNA | RNA processing tool |
| miR-544 | MicroRNA targeting WDR12 | Involved in myocardial ischemia-reperfusion injury |
| Autophagy-associated mRNAs | Transcripts stabilized by HuR | Calcific aortic valve disease |
| CHEK2 splicing variants | Alternatively spliced isoforms | Colorectal cancer chemoresistance |
| Brown adipose tissue RNA regulators | Transcripts modulated by SIRT7 | Energy expenditure and thermogenesis |
| Porcine oocyte RNA metabolism genes | Ontology group highly regulated | In vitro maturation |
| Bacterial small RNAs | RNA-mediated regulation | Gram-positive pathogen adaptation |
| Rcs phosphorelay proteins | Signal transduction to RNA regulators | Bacterial regulatory cascade |
How Is positive regulation of RNA metabolic process Regulated?
Positive regulation of RNA metabolic process is itself regulated at multiple levels. In porcine oocytes, the ontology group is highly regulated during in vitro maturation, suggesting developmental control. SIRT7 modulates RNA metabolic processes in brown adipose tissue, linking metabolic state to RNA regulation. In bacteria, the Rcs regulatory cascade and RNA-mediated regulation in Gram-positive pathogens demonstrate environmental control of RNA metabolism [7,8]. Additionally, noncoding RNAs such as circMIRIAF and PRDM16-DT can fine-tune RNA metabolic positive regulation in disease contexts [1,5].
positive regulation of RNA metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| circMIRIAF | Myocardial ischemia-reperfusion injury | Knockout or overexpression in cardiomyocytes |
| PRDM16-DT | Colorectal cancer metastasis and chemoresistance | Knockout and knock-in in colorectal cancer cell lines |
| Human antigen R (HuR) | Calcific aortic valve disease | Overexpression and knockout in valve interstitial cells |
| SIRT7 | Metabolic disorders, thermogenesis | Knockout mice and brown adipocytes |
| CHEK2 | Colorectal cancer chemoresistance | Point mutation knock-in in cancer cells |
Cardiovascular disease
Positive regulation of RNA metabolic process is implicated in myocardial ischemia-reperfusion injury, where circMIRIAF aggravates injury via targeting miR-544/WDR12 axis. In calcific aortic valve disease, human antigen R regulates autophagic flux by stabilizing autophagy-associated mRNA, linking RNA metabolic positive regulation to valve pathology.
Cancer
LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance, demonstrating how positive regulation of RNA metabolism can influence tumor progression. Dysregulated RNA processing and stability are hallmarks of cancer, and targeting these pathways is a therapeutic strategy.
Metabolic disorders
SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice, indicating that RNA metabolic positive regulation contributes to metabolic homeostasis. Disruption of this regulation may contribute to obesity and metabolic syndrome.
Infectious disease
RNA-mediated regulation in Gram-positive pathogens, including group A Streptococcus, and the complex Rcs regulatory cascade in bacteria illustrate how positive regulation of RNA metabolism is critical for bacterial adaptation and virulence [7,8].
From positive regulation of RNA metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate RNA metabolism? | CRISPR knockout in cell lines followed by RNA-seq [5,6] |
| Does a specific point mutation alter RNA metabolic regulation? | CRISPR point mutation knock-in |
| Does overexpression of gene X enhance RNA metabolism? | CRISPR overexpression or cDNA overexpression [1,6] |
| Does a tagged version of gene X localize to RNA processing compartments? | Tagged knock-in (e.g., GFP) |
| Does gene X regulate splicing of target Y? | Knockout and minigene splicing reporter |
| Does gene X affect RNA stability? | Knockout and RNA stability assays (actinomycin D) |
How to Study the positive regulation of RNA metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript abundance and splicing | Identify RNA metabolic changes after gene knockout |
| Microarray | Gene expression profiling | Ontology group enrichment in oocytes |
| CLIP-seq/RIP-seq | RNA-protein binding sites | Map HuR targets in disease |
| Minigene splicing reporter | Splicing efficiency | Test PRDM16-DT regulation of CHEK2 |
| CRISPR knockout | Loss-of-function effects | Causal gene validation [5,6] |
| CRISPR knock-in | Point mutations or tags | Study specific variants |
| Actinomycin D assay | RNA stability | Measure mRNA half-life |
| Ribozyme/spliceozyme assays | RNA cleavage/ligation | Engineered RNA processing |
Transcriptomic profiling
RNA-seq and microarray approaches are used to identify genes and ontology groups regulated under conditions of interest. For example, microarray analysis identified positive regulation of RNA metabolic process as highly regulated in porcine oocytes matured in vitro.
RNA-protein interaction assays
CLIP-seq, RIP-seq, and pull-down assays can map RNA-binding proteins such as human antigen R to their target mRNAs, revealing how they stabilize transcripts.
Splicing analysis
RT-PCR, minigene reporters, and long-read sequencing can detect splicing changes mediated by factors like PRDM16-DT and CHEK2.
Functional genomics with CRISPR
CRISPR knockout, knock-in, and overexpression screens enable causal testing of genes annotated to positive regulation of RNA metabolic process [5,6].
How CRISPR Can Be Used to Study GO:0051254 positive regulation of RNA metabolic process
Knockout
CRISPR knockout is used to delete genes involved in positive regulation of RNA metabolic process, such as PRDM16-DT or human antigen R, to assess loss-of-function phenotypes in cancer and cardiovascular models [5,6].
Point Mutation
Point mutation knock-in can introduce specific amino acid changes or splice-site mutations to dissect the functional domains of RNA metabolic regulators like CHEK2.
Knock-in
Tagged knock-in (e.g., GFP or FLAG) allows visualization and immunoprecipitation of RNA metabolic regulators to study their localization and interactions.
Overexpression
CRISPR activation or cDNA overexpression can boost levels of positive regulators such as circMIRIAF or HuR to test gain-of-function effects on RNA metabolism and disease phenotypes [1,6].
How EDITGENE Supports positive regulation of RNA metabolic process Research
Researchers studying positive regulation of RNA metabolic process-related genes often need to determine whether a candidate gene is causally involved in RNA metabolism, and CRISPR-based models provide the most direct approach.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of RNA metabolic process research.
Frequently Asked Questions About positive regulation of RNA metabolic process
What is GO:0051254 positive regulation of RNA metabolic process?
GO:0051254 is a Gene Ontology biological_process term defined as any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving RNA.
What genes are involved in positive regulation of RNA metabolic process?
Genes include circMIRIAF, WDR12, SIRT7, PRDM16-DT, CHEK2, and human antigen R, among others [1,4,5,6].
How is positive regulation of RNA metabolic process studied?
It is studied using RNA-seq, microarray, CLIP-seq, splicing reporters, and CRISPR knockout or knock-in models [2,5,6].
Why is positive regulation of RNA metabolic process important in disease?
Dysregulation contributes to myocardial ischemia-reperfusion injury, colorectal cancer, calcific aortic valve disease, and metabolic disorders [1,4,5,6].
What are the synonyms for GO:0051254?
Synonyms include activation of RNA metabolic process, positive regulation of RNA metabolism, stimulation of RNA metabolic process, up regulation of RNA metabolic process, up-regulation of RNA metabolic process, and upregulation of RNA metabolic process.
Which ontology does GO:0051254 belong to?
GO:0051254 belongs to the biological_process ontology.
Can CRISPR be used to study positive regulation of RNA metabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process [5,6].
What is an example of positive regulation of RNA metabolic process in development?
In porcine oocytes matured in vitro, the ontology group positive regulation of RNA metabolic process is highly regulated, indicating its role in oocyte maturation.
How does human antigen R relate to RNA metabolic positive regulation?
Human antigen R stabilizes autophagy-associated mRNA, thereby positively regulating RNA metabolism in calcific aortic valve disease.
What diseases are linked to GO:0051254?
Diseases include myocardial ischemia-reperfusion injury, colorectal cancer, calcific aortic valve disease, and metabolic disorders such as obesity [1,4,5,6].
Conclusion
GO:0051254 positive regulation of RNA metabolic process is a broad yet essential ontology term that captures the upregulation of RNA-related reactions. It is highly relevant to development, metabolism, and disease, with experimental evidence from oocyte maturation, cardiovascular injury, cancer, and bacterial pathogenesis [1,2,4,5,6,7,8]. CRISPR-based models and multi-omics methods provide powerful tools to dissect the genes and mechanisms underlying this process, offering opportunities for therapeutic intervention.
References
- 1. Yin L et al.. 2024. circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis.. Redox Biol 73:103175 PMID: 38795544
- 2. Celichowski P et al.. 2018. "Positive Regulation of RNA Metabolic Process" Ontology Group Highly Regulated in Porcine Oocytes Matured In Vitro: A Microarray Approach.. Biomed Res Int 2018:2863068 PMID: 29546053
- 3. Zhu J et al.. 2023. A Hairpin Ribozyme Derived Spliceozyme.. Chembiochem 24(13):e202300204 PMID: 37184100
- 4. Yoshizawa T et al.. 2022. SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice.. Nat Commun 13(1):7439 PMID: 36509749
- 5. Hu HF et al.. 2024. LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance.. Theranostics 14(8):3317-3338 PMID: 38855188
- 6. Fang J et al.. 2023. Human antigen R regulates autophagic flux by stabilizing autophagy-associated mRNA in calcific aortic valve disease.. Cardiovasc Res 119(11):2117-2129 PMID: 37183487
- 7. Wall E et al.. 2018. The Complex Rcs Regulatory Cascade.. Annu Rev Microbiol 72:111-139 PMID: 29897834
- 8. Miller EW et al.. 2014. RNA-mediated regulation in Gram-positive pathogens: an overview punctuated with examples from the group A Streptococcus.. Mol Microbiol 94(1):9-20 PMID: 25091277
